<--- Back to Details
First PageDocument Content
Molecular biology / Viruses / Animal virology / Double-stranded RNA viruses / Virus-like particle / Hepatitis E / Virus / Capsid / Capsomere / Biology / Virology / Microbiology
Date: 2009-09-20 18:58:40
Molecular biology
Viruses
Animal virology
Double-stranded RNA viruses
Virus-like particle
Hepatitis E
Virus
Capsid
Capsomere
Biology
Virology
Microbiology

Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding Tom S. Y. Guua,1, Zheng Liub,1, Qiaozhen Yea, Douglas A. Mataa, Kunpeng Lic, Changcheng Yinb, Jingqiang Zhangc,

Add to Reading List

Source URL: www.bioc.rice.edu

Download Document from Source Website

File Size: 3,48 MB

Share Document on Facebook

Similar Documents

The UNM Interdisciplinary HPV Prevention Center

The UNM Interdisciplinary HPV Prevention Center

DocID: 1rtWC - View Document

IMMUNOTHERAPIES MOVING FORWARD  COMPANY Agilvax is a biotechnology company developing targeted cancer stem cell immunotherapies and vaccines for infectious diseases. The company’s

IMMUNOTHERAPIES MOVING FORWARD COMPANY Agilvax is a biotechnology company developing targeted cancer stem cell immunotherapies and vaccines for infectious diseases. The company’s

DocID: 1qztD - View Document

SUPPLEMENT ARTICLE  Impact of Ebola Mucin-Like Domain on Antiglycoprotein Antibody Responses Induced by Ebola Virus-Like Particles Osvaldo Martinez,1,a Lee Tantral,1,a Nirupama Mulherkar,2 Kartik Chandran,2 and Christoph

SUPPLEMENT ARTICLE Impact of Ebola Mucin-Like Domain on Antiglycoprotein Antibody Responses Induced by Ebola Virus-Like Particles Osvaldo Martinez,1,a Lee Tantral,1,a Nirupama Mulherkar,2 Kartik Chandran,2 and Christoph

DocID: 1q28Y - View Document

Department of  Eukaryote Genetic Engineering Senior Scientist and Head Gintautas Žvirblis, PhD

Department of Eukaryote Genetic Engineering Senior Scientist and Head Gintautas Žvirblis, PhD

DocID: 1pIGC - View Document

IMMUNOTHERAPIES MOVING FORWARD  COMPANY Agilvax is a biotechnology company developing targeted cancer stem cell immunotherapies and vaccines for infectious diseases. The company’s

IMMUNOTHERAPIES MOVING FORWARD COMPANY Agilvax is a biotechnology company developing targeted cancer stem cell immunotherapies and vaccines for infectious diseases. The company’s

DocID: 1ovZf - View Document